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Abstract: Background: Spontaneously hypertensive rats (SHR) represent a model 
of hypertension and vascular injury. In the past decade, SHR were also considered as 
a model of vascular dementia. Several studies have shown that cerebrovascular 
changes in SHR may mimic brain vascular diseases of hypertensive individuals. 
Vascular and cerebrovascular changes during hypertension are often linked to 
inflammatory processes. Inflammation frequently affects vascular endothelium, 
perivascular astrocytes that form blood brain barrier. This inflammatory reaction 
may lead to neuro-inflammation with consequent damage of brain tissue. A 
significant brain atrophy, a reduction of white matter volumes, and BBB dysfunction 
were found in SHR. Micro- and macrogliosis in deep cortical regions were also 
observed. Based on these findings, this study was designed to define neuroinflammation entity in SHR, 
using immunohistochemistry technique for different inflammatory markers. 
Methods: Thirty-two-week-old SHR and age-matched Wistar Kyoto rats were used. Brain was 
processed for immunohistochemistry. Astrogliosis markers for astrocytes (glial fibrillary acidic protein) 
and microglia (isolectin IB4) were used. The pro-inflammatory interleukins (IL-1b, IL-6) and tumor 
necrosis factor alpha (TNFa) expression were also evaluated. 
Results: In SHR brain, an obvious glial reaction was found both for GFAP-immunoreactive astrocytes 
and for microglia. The pro-inflammatory IL-1b was significantly increased in CA1 sub-field of SHR 
hippocampus. The TNFa expression was higher in frontal cortex of SHR compared to WKY. 
Conclusion: The above neuromorphological evidences indicate that SHR are predictive animal models 
for vascular brain disorders and neuroinflammation. Furthermore, this model may be useful to evaluate 
anti-inflammatory and neuroprotective effects of different molecules. 
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INTRODUCTION 
 Hypertension is an endemic health challenge of 
industrialized countries where diet, life style and stress 
relentlessly contribute to its development [1]. Currently, the 
pharmaceutical industry, using different chemical 
compounds, being created in medicinal chemistry labs 
through pharmaceutical research and innovation, is trying to 
manage this insidious and sly disorder. Many people around 
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the world remain oblivious of the fact they suffer from 
hypertension and its related complications. A large segment 
of the population has never tried to measure or control their 
blood pressure. Therefore, they do not know their 
predisposition to cardiovascular and other diseases. All of 
these risk factors lead to an important pathology that 
involves different organs (e.g. heart, kidney and brain) [2].  
 Among other features of hypertension, its role as an 
inflammatory cause is quite controversial. Different data 
suggest that inflammation is involved in the pathogenesis of 
hypertension [3]. In fact, it was discovered that the presence 
of T lymphocytes and other immunological cells in the 
kidneys and peripheral vasculature contributes to the end 
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organ damage associated with this disease in animal model 
of hypertension [4]. 
 In some model of mice knockout for RAG-1- /-, it was 
observed that the T cells play an important role in the genesis 
of hypertension [5]. RAG-1-/- mice lacking T and B cells 
demonstrated a reduced blood pressure increase due to both 
angiotensin II infusion and deoxycorticosterone acetate plus 
sodium chloride (DOCA-salt) hypertension [5]. It should be 
highlighted that in this model, the circulating angiotensin II 
levels are suppressed [6]. There are clear evidence that 
angiotensin II increases the expression of CD69. This 
molecule is involved in lymphocyte proliferation and works 
as a signal-transmitting receptor in lymphocytes [e.g., natural 
killer (NK) cells] [7]. In addition, CD69 represents an early 
marker of T cell activation.  
 The effects of hypertension on brain is largely studied [8, 
9]. The brain represents one of the principal organs damaged 
by hypertension [10]. Different cerebrovascular disorders 
due to hypertension lead to neural damages in some patients 
with stroke.  
 Spontaneously hypertensive rats (SHR) represent an 
excellent model of human hypertension [11, 12]. They have 
been studied in over 20.000 papers since 1969 (data from 
Pubmed). This animal model, as other animal model of 
diseases, may not be an exact overlap to human disease, but 
it has a great advantage to represent a genetic type of 
hypertension [11]. Different organ damages due to 
hypertension were analyzed in SHR. Heart, renal, retinal, 
and cerebral alterations are among these aberrations [11, 13, 
14]. However, in each one of these areas, the vessel damage 
represents a principal cause of organ injury [14].  
 The hypertension correlation with inflammation is rather 
controversial. In a recent study, the authors have analyzed 
the effects of some important risk factor (e.g. obesity) on 
brain inflammation. They concluded that the obesity as other 
risk factors leads to brain inflammation that may be 
translated in an abnormal activation of sympathetic nervous 
system and in the last phase, may lead to neurogenic 
hypertension [15]. 
 However, many other authors affirm that hypertension 
damages the vessel endothelium and some inflammatory 
events could be revealed.  
 In this work, using immunohistochemistry technique to 
identify different inflammatory markers in SHR brain and 
control Wistar Kyoto (WKY), the appropriateness of this 
model to evaluate the neuroinflammation due to hypertension 
was studied.  
MATERIALS AND METHODS 
 Thirty-two-week-old male SHR (404.2 ± 22.8 g, n=6) 
and age-matched WKY rats (406.8 ± 65.7 g, n=6) were used. 
Each cage housed two animals (size 26x41 cm) and placed in 
the experimental room for acclimatization 24 h before 
testing. The animals were fed with standard laboratory diet 
and with tap water ad libitum, and kept at 23±1 °C with a 12 
h light/dark cycle, light at 7 a.m. Animal manipulations were 
carried out according to the National and European 
Community Guidelines for Animal Care (DL 116/92, of 
application of the European Communities Council Directive 
86/609/EEC and Directive 2010/63/EU) and of ethical 
guidelines of the University of Camerino. All efforts were 
made to minimize animal suffering and to reduce the number 
of animals used. 
 Before their death, animals were anaesthetised with 
pentobarbital sodium (50 mg/kg, i.p.) and then were 
decapitated. The brain was removed from skull, washed, 
weighed, fixed in a Histochoice solution and embedded in 
semi-synthetic paraffin. Serial sagittal consecutive 8 µm 
thick sections from lateral 1,40 to 2,40 mm were stained with 
Nissl's method (cresyl violet 1.5%) for assessing the 
occurrence of relevant microanatomical changes.  
Immunohistochemistry 
 Serial consecutive sagittal sections were processed for 
immunohistochemistry to detect GFAP as a marker of 
astroglial reaction, IL-1β, IL-6 and TNF-α as pro-
inflammatory markers.  
 The 1st, 6th, 11th, 16th, and 21st consecutive sections were 
processed for GFAP immunohistochemistry using a mouse 
serum against GFAP as detailed in Table 1. 
 The 2nd, 7th, 12nd, 17th and 22th consecutive sections were 
processed for Il-1β immunohistochemistry by exposing them 
to a polyclonal antibody raised against IL-1β. 
 The 3rd, 8th, 13th, 18th and 23th consecutive sections  
were processed for IL-6 immunohistochemistry (Table 1) 
and the 4th, 9th, 14th, 19th and 24th were used for 
immunohistochemical detection of TNFα (Table 1). To test 
the specificity of different primary antibodies the 5th, 10th, 
15th, 20th and 25th were used as control sections and exposed 
to a non-immune IgG instead of the primary antibody. 
Another group of consecutive section was used for lectin 
histochemistry using Lectin from Bandeiraea simplicifolia 
(Griffonia simplicifolia) Isolectin B4 (BSI-B4) peroxidase 
conjugated, (Cat. No. L5391 SIGMA. Sigma-Aldrich, St. 
Louis, MO, USA). 
 After re-hydration, sections were incubated with Tris-
HCl 20mM, EDTA 0,65mM Tween 20 0,0005% pH 9, in a 
microwave for 5 min (two times) for antigen retrieval.  
 Sections used for immunohistochemistry after a pre-
incubation in 3% PBS-bovine serum albumin for 1 h, they 
were exposed overnight in a moist chamber at 4°C to 
primary antibodies (Table 1) and then for 30 min at 25°C to 
corresponding secondary biotinylated antibodies (Table 1) 
diluted to 1:200. After incubation for 30 min with Avidin-
Biotin-Complex (VECTASTAIN ABC Kit, Vector 
laboratories, Burlingame, Ca, USA). The product of immune 
reaction was revealed using 3,3'-diaminobenzidine as a 
chromogen (Peroxidase Substrate Kit, Vector laboratories, 
Burlingame, Ca, USA).  
 For isolectin B4 (IB4) histochemistry, after pre-
incubation with 3% H2O2 the sections were incubated 
overnight with a solution of isolectin in PBS diluted 1:100. 
The isolectin binding staining was revealed using 3,3'-
diaminobenzidine as a substrate (Peroxidase Substrate Kit, 
Vector laboratories, Burlingame, Ca, USA).  
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 The sections were counterstain with methyl green 
solution to identify neuronal bodies. 
Image Analysis 
 Stained sections were viewed under a light microscope at 
a final magnification of x 400. Via a TV connection with a 
Nikon DS-Ri2 digital camera, images were analyzed using 
the Nikon Imaging Software Advanced Version (NIS 
Advanced System).  
 The area of astrocytes, considered as cells displaying a 
dark-brown GFAP immunoreactivity, was assessed using on 
overlap function of the NIS Advanced System. 
Morphometric data were then analyzed according to the 
protocol described in an earlier paper of our group [16]. The 
density of immunoreaction area occupied by pro-
inflammatory cytokines was measured by image analysis in 
different brain area. The intensity of immunostaining 
developed in microdensitometrically by calibrating the 
image analyzer taking as "zero" the background developed in 
sections incubated with a non-immune serum and “250” as 
the conventional value of maximum intensity of staining. 
 The area occupied by isolectin IB4 reaction was 
measured in different fields, devoid of reactive blood vessels 
of frontal cortex and hippocampus. The data were expressed 
as percentage of area occupied by IB4 structures. 
Data Analysis 
 Means of different parameters investigated were 
calculated from single animal data, and group means ± 
S.E.M. were then derived from single animal values. The 
significance of differences between means was analyzed by 
analysis of variance (ANOVA) followed by the Student’s  
t-test. 
RESULTS 
 Body weight values were similar in normotensive WKY 
rats or SHR (data not shown). Systolic blood pressure values 
were higher in SHR rats (210 ± 7 mmHg) compared to the 
normotensive WKY rats (132 ± 9 mmHg). Brain weight 
values were significantly lower in SHR (2,01 ± 0.03) than 
WKY (2,16 ± 0.05). 
 Sections processed for GFAP immunohistochemistry 
developed dark-brown astrocytes throughout frontal cortex 
and hippocampus. The immunoreaction shows an increase of 
the number of and size of parenchymal astrocytes in SHR 
compared with age-matched WKY (Fig. 1). These findings 
confirm other data previously published [12, 17].  
 
 
 
Fig. (1). Section of rat frontal cortex (A, B) and hippocampus (C, 
D) processed for glial fibrillary acidic protein (GFAP) 
immunohistochemistry. A,C: WKY rats; B,D: SHR. P: Pyramidal 
layer. Calibration bar: 10 mm. 
 
 Sections processed for IL-1β immunohistochemistry 
revealed dark-brown immunoreaction throughout brain areas 
investigated. The immunoreaction is localized in the 
extracellular spaces around the body of neurons in both 
WKY and SHR. No reaction was detected within the 
perikaryon of pyramidal neurons of frontal cortex and 
hippocampus (Fig. 2). In the frontal cortex, no difference in 
IL-1β expression was observed between WKY and SHR 
(Fig. 2). On the contrary, in the hippocampus, particularly in 
CA1 subfield, the increase of immunreation was evidenced 
in SHR compared to WKY (Fig. 2). This observation was 
confirmed by quantitative image analysis (Fig. 2).  
 No immunreaction for IL-6 was observed in different 
brain areas investigated (data not shown). The 
immunohistochemistry for TNFα   was mainly localized in
Table 1. Antibodies and concentration used in immunohostochemistry protocol. 
Primary Antibody Primary Antibody Dilution 
Primary Antibody 
Company Secondary Antibody 
Secondary Antibody 
Dilution 
Secondary Antibody 
Company 
GFAP (clone GA5) 
Mouse moloclonal 1:500 
Chemicon Millipore, 
Cat. No. 3402 
Biotinylated anti-
mouse IgG 1:200 Bethyl company 
IL-1β (H-153)) rabbit 
polyclonal IgG 1:50 
Santa Cruz 
Biotechnology 
Cat. No. SC-7884 
Biotinylated anti-
rabbit IgG 1:200 Bethyl company 
IL-6 (M-19) goat 
polyclonal IgG 1:50 
Santa Cruz 
Biotechnology 
Cat. No. SC-1265 
Biotinylated anti-goat 
IgG 1:200 Bethyl company 
TNF-α  rabbit 
polyclonal IgG 1:50 
Sigma Aldrich 
Cat. No. SAB4502982 
Biotinylated  
anti-rabbit IgG 1:200 Bethyl company 
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Fig. (2). Section of rat frontal cortex (A, B) and CA1 subfield of 
hippocampus, processed for Interleukin 1-beta (IL-1 b) 
immunohistochemistry. A,C: WKY rats ; B,D: SHR rats. P: 
Pyramidal layer. Calibration bar: 25 mm. Panel E shows the density 
of immunoreaction for IL-1 b in different groups investigated. Data 
are expressed as arbitrary units of immunoreactions (UDO). Data 
are the means + S.E.M. * p<0.05 vs WKY rats. 
 
 
 
Fig. (3). Section of rat frontal cortex (A, B) and CA1 subfield of 
hippocampus (C, D), processed for Tumor Necrosis Factor alpha 
(TNFa) immunohistochemistry. A,C: WKY rats ; B,D: SHR rats. P: 
Pyramidal layer. Calibration bar for A and B: 10 mm; calibration 
bar for C and D: 25 mm. Panel E shows the density of 
immunoreaction for TNFa in different groups investigated. The 
data are expressed as arbitrary units of immunoreactions (UDO). 
Data are the means + S.E.M. * p<0.05 vs WKY rats. 
 
axon hillock of pyramidal neurons of frontal cortex and 
hippocampus. The immunoreaction was significantly 
increased in frontal cortex (Fig. 3) but not in hippocampus of 
SHR in comparison with WKY of the same age (Fig. 3).  
 In general, The IB4 binds the terminal α -D-galactosyl 
residues and terminal N-acetyl-α-D-galactosaminyl residues 
which are present in the wall of vessels and microglial cells 
[18].  
 The IB4 reaction revealed the presence of activated 
microglial cells in the white matter of hippocampus and 
frontal cortex of SHR (Fig. 4). The IB4 reaction area was 
increased in the white matter but not in gray matter of the 
different cerebral fields investigated (Figs. 4 and 5).  
DISCUSSION 
 The last six decades have seen much study directed to 
arterial blood pressure [19]. Although there can be little 
doubt that simple palpation of the pulse was carried out by 
the early Egyptians [20] and the Yellow Emperor’s Classic 
of Internal Medicine [21], current measurement of the 
pressure in parts of the circulation really started in the 
middle of the eighteenth century with the experiments of 
Stephen Hales (For historic case study see [22]). However, 
these ancient literature and methods demonstrate that the 
medical queries regarding blood pressure drew continuous 
attention and evolution. Probably, this medical problem has 
represented an important challenge from the dawn of time.  
 As previously mentioned, hypertension’s involvement in 
inflammation and/or neuroinflammation is rather controversial. 
However, the concurrence of neuroinflammation and 
hypertension is clearly demonstrated [15, 23, 24].  
 Since 1965, the animal model of hypertension 
(Spontaneously hypertensive rat, SHR) was used to study 
different features (e.g. genesis, molecular, vascular, 
neural,…) of this systemic disorder. These animals have also 
represented the first “patients” which were treated with 
different antihypertensive drugs [25, 26]. Therefore, because 
of the presence of a number of studies regarding this model, 
there is much information concerning the development and 
evolution of hypertension [27-29]. In particular, among these 
data, should be quoted spontaneous white matter damage, 
cognitive decline and neuroinflammation [23]. 
 In this context, our previous studies and the present work 
has provided evidence for different inflammatory events 
occurring in SHR brain [12, 17, 29, 30]. Astrogliosis, and 
other effects of hypertension on cerebral tissue were also 
evaluated in different studies [23, 31, 32]. The image
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Fig. (4). Section of rat corpus callosum (A, B) and fimbria-fornix 
(C, D), processed for isolectin IB4 histochemistry. A, C: WKY rats; 
B,D: SHR rats. LV: lateral ventricle. Calibration bar: 25 mm. Panel 
E shows the area occupied by isolectin reaction in an area of 0,5mm2 
(% Area I.R.) of corpus callosum and fimbria fornix. Data are the 
means + S.E.M. * p<0.05 vs WKY rats. 
 
 
 
Fig. (5). Section of rat frontal cortex (A, B) and CA1 subfield  
of hippocampus, processed for processed for isolectin IB4 
histochemistry. A, C: WKY rats; B, D: SHR rats. P: Pyramidal 
layer. Calibration bar: 25 mm. Panel E shows the area occupied by 
isolectin reaction in an area of 0,05mm2 (% Area I.R.) of frontal 
cortex and CA1 hippocampus. Data are the means + S.E.M. 
 
analysis of some cerebral areas that are relevant for cognition 
activities (frontal cortex and hippocampus), using antibodies 
against GFAP, IL-1β, and TNFα, have clearly established 
that the hypertension in SHR of 32-weeks increases both 
astrogliosis and inflammatory markers level. Furthermore, 
the microglial activation is evident in SHR in particular in 
white matter. Although the IB4 reaction is not selective for 
microglial cells because it also binds to the endothelial cells, 
demonstrating an increase in density of reaction related to a 
greater volume of microglial cells. This picture is in line with 
the literature regarding the presence of a considerable vessel 
and micro vessel damage in these regions [23, 31, 32]. 
Microvascular brain disorder is predominantly considered an 
outcome of large artery rigidity and increased pulse pressure. 
Furthermore, pulse pressure leads to a pulsatile stress in the 
microcirculation of high flow organs such as the brain. 
Therefore, this event induces wall hypertrophy and luminal 
diameter reduction of small vessels [33, 34]. Similar data 
concerning SHR brain micro vessels were published some 
years ago [12, 13, 35]. Other morphological data have 
provided evidence for a narrowing effect of hypertension on 
corpus callosum, and an enlarging effect on cerebral 
ventricles [36]. An accurate image analysis was also carried 
out on other pivotal areas for cognition as frontal cortex, 
temporal cortex and hippocampus [36]. In SHR, both cortical 
and hippocampal areas were significantly decreased [36].  
 A pharmacological approach may be implemented to 
prevent neuroinflammation using antioxidant, anti-
inflammatory, anti-amyloidogenic, neuroprotective, and 
cognition-enhancing molecules including nutraceuticals [37]. 
Among other compounds, choline containing phospholipids 
could also be used, as they have demonstrated some anti-
inflammatory effects [12, 17]. Therefore, more detailed 
studies concerning the use of these compounds in SHR, may 
be useful to understand neuroinflammatory processes due to 
hypertension and its treatment.  
CONCLUSION 
 Gathering up, these findings together with previous data, 
it is possible to conclude that the SHR, having a 
normotensive control (WKY), accounts as an important and 
reproducible animal model concerning hypertension, and its 
correlated organ damage. subsequently, it may be used as a 
predictable model to detect the (neuro) inflammatory 
mechanisms of hypertension that involve micro vessels at the 
neurological level and other high flow organs.  
LIST OF ABBREVIATIONS 
BBB = Blood Brain Barrier  
GFAP = Glial Fibrillary Acidic Protein  
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IL-β = Interleukin-1 Beta  
IL-6 = Interleukin-6 
IB4 = Isolectin B4  
NIS = Nikon Imaging Software Advanced Version  
SHR = Spontaneouysly Hypertensive Rat  
RAG-1 - /- = Recombination-Activating Genes  
TNFα = Tumor Necrosis Fator Alpha  
WKY = Wistar Kyoto Rat  
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